explore -WSS

explore

author：Wikipedia 2025-08-26 23:46:38 - browse：58

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Listen: Wegovy in the brain & pivotal Alzheimer's data

explore

knowledge

WSS

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Digital health: a case of mistaken identity

At flashy new research hub, AstraZeneca lays out ambitious growth goals

WHO calls for emergency meeting on new China virus, as cases spread

For longer

A public scorecard can help hold safety

knowledge

explore

focus

Jerome Adams on the need for new antivirals for Covid

Google and Epic fight stronger regulation of AI in health care

Anesthesiologist group: stop taking Ozempic before surgery

How Medicaid coverage policies for immigrants impact new moms

The cancer drug shortage isn’t new — and neither are the solutions

Medicare has a new plan to address drug shortages

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

In early work, researchers turn to CRISPR to treat Alzheimer's

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

H5N1 virus can be tracked in retail milk, scientists say

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Sanders adds drug shortage policies to pandemic preparedness bill

Questions and answers about ramping up H5N1 bird flu vaccine

explore

explore

knowledge

focus